Evidence map›Paper›PMID 24115839›Full record

ReviewDrug design, development and therapy2013

8-Hydroxyquinolines: a review of their metal chelating properties and medicinal applications.

Veda Prachayasittikul, Supaluk Prachayasittikul, Somsak Ruchirawat, Virapong Prachayasittikul

Open access · goldAbstract readReview
In one paragraph

Review in Drug design, development and therapy, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 142 papers.

0numbers the graph read from it
0cells of the map it votes in
142citing papers in PubMed
21.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

142 citing papers in PubMed, 425 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Nitroxoline exerts potent anti-Antimicrobial agents and chemotherapy · 2026
    Article
  12. Article
  13. Article
  14. Article
  15. Hydroxyquinoline-functionalised aza-crown macrocycles for lanthanide coordination.Dalton transactions (Cambridge, England : 2003) · 2026
    Article
  16. Bioinspired 8‑hydroxyquinoline-FeScientific reports · 2026
    Article
  17. Zn(HQ)Micromachines · 2026
    Article
  18. Review
  19. Review
  20. Review

82 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Veda PrachayasittikulDepartment of Clinical Microbiology and Applied Technology, Faculty of Medical Technology, Bangkok, Thailand.
Supaluk Prachayasittikul
Somsak Ruchirawat
Virapong Prachayasittikul
Chulabhorn Research Institute · THMahidol University · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metal ions play an important role in biological processes and in metal homeostasis. Metal imbalance is the leading cause for many neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis. 8-Hydroxyquinoline (8HQ) is a small planar molecule with a lipophilic effect and a metal chelating ability. As a result, 8HQ and its derivatives hold medicinal properties such as antineurodegenerative, anticancer, antioxidant, antimicrobial, anti-inflammatory, and antidiabetic activities. Herein, diverse bioactivities of 8HQ and newly synthesized 8HQ-based compounds are discussed together with their mechanisms of actions and structure-activity relationships.

Indexed as

AnimalsChelating AgentsDrug DesignHumansHydroxyquinolinesMetalsOxyquinolineStructure-Activity RelationshipChelating AgentsHydroxyquinolinesMetalsOxyquinolineanticancerantidiabeticantineurodegenerativemetal binding compoundmultifunctional actionsstructure-activity relationships

Identifiers

PMID24115839
PMCPMC3793592
OpenAlexW2063039714

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.